Carmona-Bayonas, A.
Jimenez-Fonseca, P.
de Castro, E. M.
Mata, E.
Biosca, M.
Custodio, A.
Espinosa, J.
Vázquez, E. G.
Henao, F.
Ayala de la Peña, F. https://orcid.org/0000-0001-6311-920X
Article History
Received: 6 November 2018
Accepted: 8 November 2018
First Online: 23 November 2018
Compliance with ethical standards
:
: ACB have received speaker and travel grants from IPSEN, Servier, and Roche, outside the submitted work. PJF has nothing to disclose. EMC has nothing to disclose. EM has nothing to disclose. MB reports personal fees from Leo Pharma, Rovi and Sanofi, outside the submitted work. AC has nothing to disclose. JE reports personal fees from MSD, Novartis, Pfizer, BMS, Astra Zeneca and Roche, outside the submitted work. EGV has nothing to disclose. FH has nothing to disclose. FAP reports grants from Roche and Celgene, and other financial support from Roche, Celgene, Eisai, AstraZeneca, Pfizer, Pierre Fabre and Novartis, outside the submitted work.
: The current study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. This article does not contain any studies with human participants or animals performed by any of the authors.
: For this type of study, no informed consent is required.